z-logo
open-access-imgOpen Access
Stroke in Young Military Men With Heterozygous for MTHFR Gene Mutation or Factor V Leiden Gene Mutation Associated With Patent Foramen Ovale: Report of Two Cases and Therapeutic Strategy
Author(s) -
Rodrigo Tavares Brisson,
Josevânia Fulgêncio de Lima Arruda,
Liene Duarte Silva,
Dilermando Leal Júnio de Jesus,
Viviane Flumignan Zétola,
Marcia Aparecida Camacho Kauffmann Nogueira
Publication year - 2021
Publication title -
military medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 67
eISSN - 1930-613X
pISSN - 0026-4075
DOI - 10.1093/milmed/usab192
Subject(s) - medicine , methylenetetrahydrofolate reductase , patent foramen ovale , transcranial doppler , cardiology , stroke (engine) , factor v leiden , paradoxical embolism , population , thrombophilia , gene mutation , percutaneous , venous thrombosis , thrombosis , mutation , genetics , gene , genotype , mechanical engineering , biology , environmental health , engineering
We report two cases of Brazilian patients (a 22-year-old male and a 48-year-old male) with ischemic stroke, whose arterial vascular study and echocardiographic investigation did not reveal any steno-occlusive arterial disease or typical cardioembolic finding, such as atrial fibrillation or myocardial dysfunction. A transcranial Doppler ultrasound and a transesophageal echocardiogram showed a patent foramen ovale (PFO), and the laboratory screening for coagulation abnormalities showed heterozygosity for MTHFR C677T and A1298C in one of the patients and heterozygosity for factor V Leiden gene mutations in the other patient. The significance of the association of PFO with Methylenetetrahydrofolate (MTHFR) C677T and A1298C variants or factor V Leiden mutation is discussed as a possible cause of ischemic stroke through paradoxical embolism from a venous source. There is a high prevalence of these two mentioned conditions in the general population, so we discuss two cases in which indication for anticoagulant therapy or percutaneous closure of PFO prevails.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom